PlainRecalls
FDA Drug Moderate Class II Terminated

Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07

Reported: March 24, 2021 Initiated: March 8, 2021 #D-0301-2021

Product Description

Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07

Reason for Recall

Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing

Details

Recalling Firm
Akorn, Inc.
Units Affected
8,183 unit dose cups
Distribution
Nationwide USA
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07. Recalled by Akorn, Inc.. Units affected: 8,183 unit dose cups.
Why was this product recalled?
Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing
Which agency issued this recall?
This recall was issued by the FDA Drug on March 24, 2021. Severity: Moderate. Recall number: D-0301-2021.